Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Exact Sciences Stock Quote

Exact Sciences (NASDAQ: EXAS)

Price as of June 21, 2024, 4:00 p.m. ET

Exact Sciences Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
EXAS -52.81% -61.22% -17.24% +204%
S&P +24.71% +85.21% +13.10% +300%

Exact Sciences Company Info

EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

News & Analysis

The Fool has written over 300 articles on Exact Sciences.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.